Global COVID-19 vaccination uptake across the emergency and early post-emergency periods, 2021-2024
Brooks, D. J.; Germann, A.; Craw, L.; Dumolard, L.; Nedelec, Y.; Acma, A.; Schultz, C.; Mboussou, F.; Atagbaza, A.; Doshi, R. H.; Pastore, R.; Contreras, M.; Velandia Gonzalez, M.; Leon, R.; Mere, O.; Kissa, J.; Emmanuel Njambe, T. O.; Gonzales, G.; Bayutas, B.; Chang Blanc, D.; Von Dobschuetz, S.; Wilder-Smith, A.; Gacic-Dobo, M.; Van Kerkhove, M. D.; O'Brien, K. L.
Show abstract
COVID-19 vaccination helped change the course of the pandemic and remains critical for protecting high-risk groups. We analyzed data submitted to WHO to describe COVID-19 vaccination coverage during the emergency period from 2021-2023 and annual uptake in 2024, the first post-emergency calendar year after the Public Health Emergency of International Concern designation was lifted. By end-2023, global complete primary series coverage reached 65% in the total population, 82% among older adults, and 91% among health and care workers (HCWs), across reporting countries. Booster coverage was lower, at 33%, 60%, and 69%, respectively. Across indicators, disparities by country income group and region emerged early and persisted through 2024. In 2024, vaccination of older adults and HCWs was limited and heterogeneous. These findings underscore the need for stronger, sustainably financed adult immunization platforms and associated monitoring systems to enhance life-course vaccination benefits and to support future outbreak, epidemic, and pandemic responses.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Optimal age targeting for pneumococcal vaccination in older adults; a modelling study 94%
- Vaccine uptake and SARS-CoV-2 antibody prevalence among 207,337 adults during May 2021 in England: REACT-2 study 93%
- Higher serological responses and increased vaccine effectiveness demonstrate the value of extended vaccine schedules in combatting COVID-19 in England 92%
Similar papers in this journal
- Global epidemiology of SARS-CoV-2 infection: a systematic review and meta-analysis of standardized population-based seroprevalence studies, Jan 2020-Dec 2021 92%
- Information nudges for influenza vaccination: Evidence from a large-scale cluster-randomized controlled trial 91%
- Health impact and cost-effectiveness of COVID-19 vaccination in Sindh Province, Pakistan 91%
Similar papers in this journal
- Worldwide routine immunisation coverage regressed during the first year of the COVID-19 pandemic 93%
- Averted mortality by COVID-19 vaccination in Belgium between 2021 and 2023 93%
- Operational Framework and Feasibility of the GALFLU Study: A Pragmatic Individually Randomized Controlled Trial Evaluating High-Dose Versus Standard-Dose Influenza Vaccination in Older Adults 93%
Similar papers in this journal
- Impact of health system strengthening on delivery strategies to improve child immunization coverage and inequalities in rural Madagascar 93%
- Global and regional burden of attributable and associated bacterial antimicrobial resistance avertable by vaccination: modelling study 92%
- Ethnic disparities in immunisation: analyses of zero-dose prevalence in 64 low- and middle-income countries 92%
Similar papers in this journal
- Comparative effectiveness of allocation strategies of COVID-19 vaccines and antivirals against emerging SARS-CoV-2 variants of concern in East Asia and Pacific region 92%
- Comparison of control and transmission of COVID-19 across epidemic waves in Hong Kong: an observational study 92%
- Epidemiological characteristics and transmission dynamics of the outbreak caused by the SARS-CoV-2 Omicron variant in Shanghai, China: a descriptive study 88%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.